Cargando…
Evaluation of the In Vitro Antimicrobial Efficacy against Staphylococcus aureus and epidermidis of a Novel 3D-Printed Degradable Drug Delivery System Based on Polycaprolactone/Chitosan/Vancomycin—Preclinical Study
Acute and chronic bone infections, especially those caused by methicillin-resistant Staphylococcus aureus (MRSA), remains a major complication and therapeutic challenge. It is documented that local administration of vancomycin offers better results than the usual routes of administration (e.g., intr...
Autores principales: | López-González, Iván, Hernández-Heredia, Ana Belén, Rodríguez-López, María Isabel, Auñón-Calles, David, Boudifa, Mohamed, Gabaldón, José Antonio, Meseguer-Olmo, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300899/ https://www.ncbi.nlm.nih.gov/pubmed/37376211 http://dx.doi.org/10.3390/pharmaceutics15061763 |
Ejemplares similares
-
Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
por: Wu, Wei, et al.
Publicado: (2021) -
Inhibition of Staphylococcus epidermidis Biofilms Using Polymerizable Vancomycin Derivatives
por: Lawson, McKinley C., et al.
Publicado: (2010) -
Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series
por: Sotozono, Chie, et al.
Publicado: (2013) -
Mutant prevention concentration of ozenoxacin for quinolone-susceptible or -resistant Staphylococcus aureus and Staphylococcus epidermidis
por: López, Y., et al.
Publicado: (2019) -
Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis
por: Mirzaei, Rasoul, et al.
Publicado: (2022)